Építés alatt – nem éles oldal
Belépés

What researchers published on Áttétes emlőrák

30 311 papers, newest first.

Showing 40 of 30 311

  • Single-cell multiomics profiling reveals tumour microenvironment landscape and sex-specific immune-suppressive feature in male breast cancer.Clinical and translational medicine
  • Dual-database pharmacovigilance analysis based on FAERS and JADER combined with network pharmacology to explore fulvestrant-associated respiratory toxicity.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
  • Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Advanced Breast Cancer Patients Treated with Trastuzumab Deruxtecan: A Real-World Study.Journal of clinical medicine
  • MetaanalízisSurvival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis.Breast cancer research and treatment
  • Real-World Implementation of Molecular Testing and Biomarker-Guided Therapies in HR+/HER2- Metastatic Breast Cancer.Cancers
  • Time to maximal response of trastuzumab deruxtecan in patients with HER2-Positive metastatic breast cancer: A multicenter retrospective study (TRACE).Breast (Edinburgh, Scotland)
  • Early Magnetic Resonance Imaging and Single-Photon Emission Computerized Tomography Detection of Breast Cancer With Netrin-1-Specific Molecular and Liposome Probes.ChemMedChem
  • An EO771-Derived Metastatic Breast Cancer Model Exhibits RANKL-Associated Osteoimmune Remodeling Before Detectable Bone-Marrow Dissemination.Biology
  • ÁttekintésRechallenge, switch, or target? navigating advanced breast cancer after adjuvant CDK 4/6 inhibitors.Breast cancer research and treatment
  • Prognostic Value of Metabolic-Muscle Reserve Index in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.Journal of clinical medicine
  • Survival Differences Between De Novo and Recurrent HER2-Positive Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.Oncology
  • A Novel Function of Tubulin β2a and Tubulin β3 in Regulating Metastatic Properties in Bone-Metastatic Breast Cancer Cells.Cancers
  • ÁttekintésNavigating treatment for De novo oligometastatic breast cancer: The Assisi think tank meeting.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • KLRB1 (CD161) as a context-dependent prognostic marker in breast cancer: An exploratory analysis of CD4+ memory T cell infiltration: a retrospective multi-cohort study.Medicine
  • Addition of tucatinib to trastuzumab/pertuzumab after local therapy for isolated intracranial progression in HER2-positive metastatic breast cancer: primary results of the phase II BRIDGET trial.ESMO open
  • Pyramid-level training with stain normalization for breast cancer lymph-node metastasis segmentation in whole-slide images.PloS one
  • Phosphatidylserine modulation influences syncytia formation in human breast cancer cell lines.BMC cancer
  • EsetismertetésCase report: Fournier's gangrene occurring after inavolisib-induced hyperglycemia in a patient with metastatic breast cancer.Frontiers in pharmacology
  • Otological manifestations of disseminated metastatic breast cancer presenting with facial nerve palsy, tinnitus and otalgia.BMJ case reports
  • Metachronous gastric adenocarcinoma during sustained control of metastatic breast cancer.Revista espanola de enfermedades digestivas
  • ÁttekintésCellular/Molecular-assisted Early Detection of Breast Cancer: An Update.Anti-cancer agents in medicinal chemistry
  • CT-defined sarcopenia and outcomes in HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors.Frontiers in medicine
  • Cost-effectiveness of inavolisib plus palbociclib/fulvestrant versus palbociclib/fulvestrant for PIK3CA-mutated advanced breast cancer in China.Frontiers in pharmacology
  • Palbociclib, Fulvestrant, Trastuzumab, and Pyrotinib for Patients with Advanced Breast Cancer with Brain Metastases: A Prospective Multicenter Phase 2 Trial.Clinical cancer research : an official journal of the American Association for Cancer Research
  • Patterns of metastasis according to germline BRCA1/2 mutation status in patients with HER2-negative metastatic breast cancer.Breast cancer research : BCR
  • Ultra-sensitive MRD assessment in long-term complete responders to anti-HER2 therapy in HER2-positive metastatic breast cancer: initial results from HER2-CR study.ESMO open
  • Effect of different axillary management strategies on survival in elderly patients (≥70 Years) with early-stage breast cancer and 1-2 positive lymph nodes, stratified by risk factors.PloS one
  • High-Purity Magnetic Fluidic Isolation of Viable Circulating Tumor Cells Enables Single-Cell Multi-Omics Profiling.Analytical chemistry
  • Potential prognostic value of the free T3/T4 ratio in HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.BMC cancer
  • Interpreting EORTC CAT Core short-form scores in metastatic breast cancer: EQ-VAS-associated cut-points and comparison with published thresholds for clinical importance.Journal of patient-reported outcomes
  • Analytical and clinical validation of Ion Torrent™ Oncomine™ Dx Express Test for identifying PIK3CA/AKT1/PTEN-altered tumors in patients with hormone receptor-positive advanced breast cancer for treatment with capivasertib.Translational oncology
  • CD39-associated myeloid-T-cell coordination within an immunoregulatory neighborhood linked to treatment resistance in triple-negative breast cancer.Breast cancer research : BCR
  • Real-world outcomes of everolimus-based therapy after CDK4/6 inhibitor therapy in ER-positive/HER2-negative metastatic breast cancer: a multicenter registry-based study.Breast cancer (Tokyo, Japan)
  • EsetismertetésBreast metastasis from BRCA1-mutated ovarian cancer: response to parp inhibition and a potential lymphatic route.BMC women's health
  • Dual Primary Malignancies in Breast Cancer: Clinical Characteristics and Survival Predictors Among Hakka Women in Meizhou.Breast cancer (Dove Medical Press)
  • EsetismertetésSequential Anti-HER2 (Human Epidermal Growth Factor Receptor 2) Therapy and Late-Line Tucatinib in Patients With HER2-Positive Breast Cancer and Brain Metastases: A Real-World Case Report.Cureus
  • TP53 shapes tumour-specific immune phenotypes across breast, colorectal and kidney human cancers.Journal of molecular medicine (Berlin, Germany)
  • ÁttekintésMechanotransduction in breast cancer and implications for preclinical modeling.Cancer metastasis reviews
  • FOSL2 expression in histologically diagnosed breast cancer: first immunohistochemical evidence from Cameroon.BMC cancer
  • EsetismertetésExperience with pyrotinib monotherapy for advanced HER2-positive breast cancer with diffuse hepatic metastases and severe hepatic dysfunction: a case report.International journal of surgery case reports